One regulatory note worth holding alongside his framing: the FDA placed several of the peptides he discusses (including BPC-157, CJC-1295, and Ipamorelin) onto a Category 2 list in 2023, citing a lack of safety data rather than reported harms
They are convenient to use, but several factors, including your diet and the presence of digestive enzymes, can influence their absorption
Protects healthcare providers legally
This mechanism is supported by peer-reviewed research, including studies by Khavinson and colleagues published in gerontology journals, confirming its biological effects
Always discuss your supplement routine with your family doctor or pharmacist if you are taking prescription medications.
Recalls & Warnings January 17, 2018 Joint and Pain Relief Product Contains Undeclared Drug On January 17, 2018 Health Canada warned consumers that Linsen Double Caulis Plus, a supplement for joint pain, was found to contain the undeclared drug dexamethasone